tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

BLTE Stock Latest News

Belite Bio price target raised to $110 from $60 at Maxim
The FlyBelite Bio price target raised to $110 from $60 at Maxim
1M ago
BLTE
Belite Bio price target raised to $100 from $60 at H.C. Wainwright
PremiumThe Fly
Belite Bio price target raised to $100 from $60 at H.C. Wainwright
1M ago
BLTE
Belite Bio Advances in Retinal Disease Trials
PremiumCompany Announcements
Belite Bio Advances in Retinal Disease Trials
1M ago
BLTE
Belite Bio Advances in Tinlarebant Trials, Appoints New CMO
PremiumCompany Announcements
Belite Bio Advances in Tinlarebant Trials, Appoints New CMO
1M ago
6K
BLTE
Belite Bio reports Q3 EPS (28c), consensus (29c)
PremiumThe Fly
Belite Bio reports Q3 EPS (28c), consensus (29c)
1M ago
BLTE
Is BLTE a Buy, Before Earnings?
PremiumPre-EarningsIs BLTE a Buy, Before Earnings?
1M ago
BLTE
Belite Bio Offers New Warrant Opportunities to Investors
Premium
Company Announcements
Belite Bio Offers New Warrant Opportunities to Investors
2M ago
6K
BLTE
Belite Bio announces first patient dosed in Phase 2/3 DRAGON II trial
Premium
The Fly
Belite Bio announces first patient dosed in Phase 2/3 DRAGON II trial
3M ago
BLTE
Belite Bio Welcomes New Chief Medical Officer
PremiumCompany Announcements
Belite Bio Welcomes New Chief Medical Officer
4M ago
6K
BLTE
Belite Bio announces appointment of Hendrik Scholl as Chief Medical Officer
PremiumThe Fly
Belite Bio announces appointment of Hendrik Scholl as Chief Medical Officer
4M ago
BLTE
Belite Bio price target raised to $60 from $59 at H.C. Wainwright
PremiumThe Fly
Belite Bio price target raised to $60 from $59 at H.C. Wainwright
4M ago
BLTE
BLTE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BLTE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
BLTE
Belite Bio Advances Novel Retinal Disease Treatment
PremiumCompany AnnouncementsBelite Bio Advances Novel Retinal Disease Treatment
4M ago
6K
BLTE
Belite Bio reports Q2 EPS (26c), consensus (25c)
Premium
The Fly
Belite Bio reports Q2 EPS (26c), consensus (25c)
4M ago
BLTE
Belite Bio granted Sakigake Designation by Japan MHLW
Premium
The Fly
Belite Bio granted Sakigake Designation by Japan MHLW
6M ago
BLTE
Belite Bio Advances Retinal Disease Treatment
PremiumCompany Announcements
Belite Bio Advances Retinal Disease Treatment
7M ago
6K
BLTE
Belite Bio reports Q1 EPS (33c), consensus (28c)
PremiumThe Fly
Belite Bio reports Q1 EPS (33c), consensus (28c)
7M ago
BLTE
Belite Bio participates in a webinar with Cantor Fitzgerald
PremiumThe Fly
Belite Bio participates in a webinar with Cantor Fitzgerald
7M ago
BLTE
Belite Bio participates in a webinar with Cantor Fitzgerald
PremiumThe Fly
Belite Bio participates in a webinar with Cantor Fitzgerald
7M ago
BLTE
Belite Bio participates in a webinar with Cantor Fitzgerald
PremiumThe FlyBelite Bio participates in a webinar with Cantor Fitzgerald
7M ago
BLTE
Belite Bio presents additional analysis from Phase 2 study of tinlarebant
Premium
The Fly
Belite Bio presents additional analysis from Phase 2 study of tinlarebant
8M ago
BLTE
Belite Bio to participate on KOL Webinar to discuss STGD1, GA
Premium
The Fly
Belite Bio to participate on KOL Webinar to discuss STGD1, GA
8M ago
BLTE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >